These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6319879)

  • 1. Endogenous opioid peptides: comparative evaluation of their receptor affinities in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Höllt V; Lee NM; Loh HH
    Life Sci; 1983; 33 Suppl 1():291-4. PubMed ID: 6319879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A; James IF
    Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of p-nitrophenylalanine enkephalins with mu-, delta- and kappa-subtypes of the opiate receptor.
    Fauchère JL; Do KQ; Schwyzer R; Robson LE; Gillan MG; Paterson SJ; Kosterlitz HW
    Eur J Pharmacol; 1982 Feb; 77(4):339-42. PubMed ID: 6277677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors.
    Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1985 Jul; 225(1238):27-40. PubMed ID: 2863824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of opioid receptors: relation to antinociception.
    Kosterlitz HW; Paterson SJ
    Philos Trans R Soc Lond B Biol Sci; 1985 Feb; 308(1136):291-7. PubMed ID: 2858883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate peptide receptor types on cultured mouse spinal neurons.
    Jia M; Nelson PG
    Peptides; 1987; 8(3):559-63. PubMed ID: 2889202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H] dynorphin binding to guinea pig and rat brain.
    Young E; Walker JM; Houghten R; Akil H
    Life Sci; 1983; 33 Suppl 1():287-90. PubMed ID: 6141490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mu-, delta- and kappa-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides.
    Schiller PW; Nguyen TM; DiMaio J; Lemieux C
    Life Sci; 1983; 33 Suppl 1():319-22. PubMed ID: 6319885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of distinct binding site subunits of mu and delta opioid receptors.
    Howard AD; Sarne Y; Gioannini TL; Hiller JM; Simon EJ
    Biochemistry; 1986 Jan; 25(2):357-60. PubMed ID: 3006757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple opiate receptors: differential binding of mu, kappa and delta agonists.
    Wood PL; Charleson SE; Lane D; Hudgin RL
    Neuropharmacology; 1981 Dec; 20(12A):1215-20. PubMed ID: 6275292
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential postnatal development of mu and delta opiate receptors.
    Wohltmann M; Roth BL; Coscia CJ
    Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.